Browse every story filed under this topic, curated from trusted publishers around the world.
STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent years dealing with addiction treatment.
Read full story →
STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at …
STAT+: Hair-raising trial results, and Servier’s M&A wishlist
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The …
STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, peptides, diet …
STAT+: As artificial intelligence show off diagnostic chops, scientists reckon with the way forward
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical …
STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case
Elevance said a top exec would depart, days after the Justice Department asked to depose him.
STAT+: Five-way obesity drug is super effective — in mice
A 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The Readout
STAT+: Cigna will exit ACA individual markets next year, adding to tumult for patients
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
STAT+: FDA wants to exclude weight-loss drugs from a compounding list
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs …
STAT+: Hinge has a new FDA-cleared migraine device
In this edition of STAT Health Tech: FDA's plan to use AI to speed up trials, Hinge's new migraine device, …
STAT+: Democrats go hard on health care affordability
The Senate's top Democrat unveiled a health policy outline that calls for lowering patients' costs across the board.
STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift …
STAT+: What does Akeso’s primo plenary spot say about its survival data?
Mystery cloaks an ASCO plenary lung cancer survival result.
STAT+: New obesity tool aims to predict risk of 18 serious complications
A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include …
29 games in, Padres' Fernando Tatis Jr. yet to add a key hitting stat
Fernando Tatis Jr. struggling to get it out.
Travis Bazzana's .000 average proven not a problem by this stat
Bazzana is still looking for his first hit.
STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.
STAT+: Why conversations around health AI may be evolving beyond hype
In this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how …
STAT+: A patent win for Pfizer and BridgeBio
A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The …
STAT+: Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
The FDA announced efforts to make clinical trials more efficient, starting by reviewing data in real time from trials conducted …
You've seen all articles for #stat.
Check back
soon
for new stories.